IRLAB Therapeutics AB Stock OTC Markets
Stocks
IRLA.F
SE0012675361
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 07-01 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 192M 19.87M 17.37M 16.03M 14.77M 27.84M 1.91B 28.46M 75.34M 937M 74.63M 72.99M 3.23B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 192M 19.87M 17.37M 16.03M 14.77M 27.84M 1.91B 28.46M 75.34M 937M 74.63M 72.99M 3.23B | EV / Sales 2026 * |
1.88x | EV / Sales 2027 * | 1.35x |
| Free-Float |
38.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 19.87M | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| Average | -0.06% | +0.54% | +28.54% | +53.91% | 397.23B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.58M 9.25M 8.53M 7.87M 14.83M 1.02B 15.16M 40.12M 499M 39.74M 38.87M 1.72B | 142M 14.71M 12.86M 11.86M 10.94M 20.61M 1.42B 21.07M 55.77M 694M 55.25M 54.04M 2.39B |
| Net income | -32.6M -3.38M -2.96M -2.73M -2.51M -4.74M -326M -4.84M -12.82M -160M -12.7M -12.42M -549M | 33.3M 3.45M 3.02M 2.79M 2.57M 4.84M 333M 4.95M 13.1M 163M 12.97M 12.69M 561M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
- IRLA.F Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
